PRODUCT DETAILS

About Dynulta Tablet

SUCROFERRIC OXYHYDROXIDE belongs to the class of medications called mineral supplements indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. 

SUCROFERRIC OXYHYDROXIDE contains 'sucroferric oxyhydroxide'. It helps to lower phosphate levels in the blood and prevents complications caused by high phosphate levels in the blood, especially in dialysis patients who are unable to eliminate excess phosphate levels.

Uses of Dynulta Tablet

Hyperphosphatemia (high phosphate levels in the blood).

Medicinal Benefits of Dynulta Tablet

SUCROFERRIC OXYHYDROXIDE contains sucroferric oxyhydroxide indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. SUCROFERRIC OXYHYDROXIDE helps to lower phosphate levels in the blood and prevents issues caused by high phosphate levels in the blood, especially in dialysis patients who are unable to get rid of excess phosphate levels.

Directions for Use

SUCROFERRIC OXYHYDROXIDE must be taken with meals or as directed by a physician. Swallow it as a whole with water.

Side Effects of Dynulta Tablet

• Diarrhoea
• Nausea
• Vomiting
• Constipation
• Indigestion

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Drug Interaction:

SUCROFERRIC OXYHYDROXIDE may interact with certain medications used to treat bladder cancer (erdafitinib), antibiotic (doxycycline), hormone (levothyroxine).

Safety Advice

ALCOHOL

It is not recommended to drink alcohol while taking SUCROFERRIC OXYHYDROXIDE because it may cause unpleasant side effects.